Respiratory syncytial virus infection in adults

HH Nam, MG Ison - bmj, 2019 - bmj.com
Human respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae
family, Orthopneumovirus genus. It is a negative sense, single stranded RNA virus that …

Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle

S Bos, L Milross, AJ Filby, R Vos… - European Respiratory …, 2022 - Eur Respiratory Soc
Lung transplantation is the optimal treatment for selected patients with end-stage chronic
lung diseases. However, chronic lung allograft dysfunction remains the leading obstacle to …

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

KC Meyer, G Raghu, GM Verleden, PA Corris, P Aurora… - 2014 - Eur Respiratory Soc
Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that
is associated with poor survival. The International Society for Heart and Lung …

Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis

E Ofek, M Sato, T Saito, U Wagnetz, HC Roberts… - Modern …, 2013 - nature.com
We previously described restrictive allograft syndrome as a form of chronic lung allograft
dysfunction, demonstrating restrictive pulmonary function decline. However, the …

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

J Gottlieb, MR Zamora, T Hodges, AW Musk… - The Journal of Heart and …, 2016 - Elsevier
Background Respiratory syncytial virus (RSV) infection in lung transplant (LTx) patients is
associated with an increased incidence of bronchiolitis obliterans syndrome (BOS). ALN …

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation

R Vos, BM Vanaudenaerde… - European …, 2011 - Eur Respiratory Soc
Azithromycin reduces airway inflammation and improves forced expiratory volume in 1 s
(FEV1) in chronic rejection or bronchiolitis obliterans syndrome (BOS) after lung …

[PDF][PDF] Эфферентная терапия. Мембранный плазмаферез

ВА Воинов - СПб.: Эскулап, 2002 - trackpore.ru
После четвёртого издания этой книги мембранные плазмофильтры и аппаратура
продолжали совершенствоваться, и возникла необходимость пятого издания, которое …

Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus

E Chiesa, R Dorati, B Conti, T Modena, E Cova… - International journal of …, 2018 - mdpi.com
Bronchiolitis obliterans syndrome (BOS), caused by lung allograft-derived mesenchymal
cells' abnormal proliferation and extracellular matrix deposition, is the main cause of lung …

Effector immune cells in chronic lung allograft dysfunction: A systematic review

S Bos, AJ Filby, R Vos, AJ Fisher - Immunology, 2022 - Wiley Online Library
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long‐term survival
after lung transplantation and improved insight into its underlying immunological …

[HTML][HTML] Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study

SS Weigt, CAF Copeland, A Derhovanessian… - American Journal of …, 2013 - Elsevier
Aspergillus colonization after lung transplantation may increase the risk for bronchiolitis
obliterans syndrome (BOS), a disease of small airways. We hypothesized that colonization …